Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of salvianolic acid A in preparation of medicine for preventing thrombotic cerebral ischemia

A technology of cerebral ischemia and salvianolic acid, which is applied in the field of medicine, can solve the problems of no salvianolic acid A, etc., and achieve the effect of protecting cerebral vascular endothelial function, improving nerve function, hemorrhagic transformation, or alleviating the degree of bleeding

Pending Publication Date: 2021-12-24
INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above studies on the effect of salvianolic acid A are all on the therapeutic effect of cerebral ischemia, and there are no related studies on the prevention of cerebral ischemic diseases by salvianolic acid A alone and the prevention of cerebral hemorrhage diseases at the same time. to report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of salvianolic acid A in preparation of medicine for preventing thrombotic cerebral ischemia
  • Application of salvianolic acid A in preparation of medicine for preventing thrombotic cerebral ischemia
  • Application of salvianolic acid A in preparation of medicine for preventing thrombotic cerebral ischemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Example 1. Effect of prophylactic administration of salvianolic acid A (10 mg / kg) on ​​the neuroprotective function of rats with acute stroke.

[0050] Experimental materials: male SD rats, weighing 220-260 g, purchased from Weitong Lihua (Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.). Salvianolic acid A powder was provided by the National Center for Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences. Aspirin was purchased from Sigma, USA. Sodium carboxymethyl cellulose was purchased from Sinopharm Chemical Reagent Co., Ltd.

[0051] Experimental grouping: 40 SD rats in total, 10 in each group, were given 0.5% sodium carboxymethylcellulose and aspirin 100mg·kg by intragastric administration to the blank group respectively. -1 And salvianolic acid A 10mg·kg -1 , once in the morning and once in the evening, for 5 consecutive days, and on the 6th day, the cerebral ischemia model was prepared by electrocoagulation autothrom...

Embodiment 2

[0054] Example 2. Effect of prophylactic administration of salvianolic acid A (10 mg / kg) on ​​cerebral hemorrhage in rats with acute stroke.

[0055] Animal modeling and administration methods are the same as in Example 1. After 24 hours of cerebral ischemia, the brain was perfused, coronally sliced, photographed, and the homogenate of the perfused brain tissue was taken, and the absorbance was detected at 400 nm according to the instructions of the hemoglobin detection kit (DIHB-250, Bosch Biotechnology Co., Ltd., USA). Calculate the hemoglobin content in the brain tissue. Hematoxylin-eosin stained tissues were stored in 4% paraformaldehyde solution for hematoxylin-eosin staining.

[0056] The result is as figure 2 As shown, hemorrhagic transformation occurred in the brain tissue after ischemia, and the cerebral hemorrhage was severe in the aspirin prophylactic administration group, while the salvianolic acid A prophylactic administration group reduced the occurrence of ce...

Embodiment 3

[0057] Example 3. Effect of prophylactic administration of salvianolic acid A (10 mg / kg) on ​​vascular endothelial function in rats with acute stroke.

[0058]Animal modeling and administration methods are the same as in Example 1. After 24 hours of cerebral ischemia, blood was collected from the abdominal aorta. After standing at room temperature for 2 hours, it was centrifuged at 1,000×g for 10 minutes. ELISA was used to detect von Willebrand factor in serum (Von Willebrand factor kit was purchased from Elabscience Co., Ltd. ) and von Willebrand factor lyase (von Willebrand factor lyase kit was purchased from Novus Company) indicators.

[0059] The protein in the brain tissue of the ischemic area was taken, added Ripa lysate to fully grind and lyse, centrifuged at 12000rpm, 4°C for 15min, and quantified the protein by BCA method. The samples were processed into samples of equal concentration and equal quality. Denatured at 100°C for 10 minutes and placed in a -20°C refrige...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicines, and particularly discloses application of salvianolic acid A in preparation of a medicine for preventing thrombotic cerebral ischemia or thrombotic cerebral ischemia combined cerebral hemorrhage related diseases, in particular to the application of the salvianolic acid A in preventing thrombotic cerebral ischemia or thrombotic cerebral ischemia combined cerebral hemorrhage related diseases. The invention discloses in-vivo and in-vitro action mechanisms of the salvianolic acid A in prevention of thrombotic cerebral ischemia or thrombotic cerebral ischemia combined cerebral hemorrhage related diseases, and discovers that the preventive administration of the salvianolic acid A can reduce the neurobehavioral score after acute cerebral ischemia and reduce the occurrence of cerebral hemorrhage and has a better protection effect on blood-brain barriers. The salvianolic acid A can be used for preventing thrombotic cerebral ischemia or thrombotic cerebral ischemia combined cerebral hemorrhage related diseases, adverse reactions are reduced, and a safe, effective and economical solution is provided for prevention of cerebral ischemia diseases.

Description

technical field [0001] The invention relates to a new application of salvianolic acid A in the preparation of medicines, mainly relates to the application of salvianolic acid A in the preparation of medicines for preventing thrombotic cerebral ischemia or thrombotic cerebral ischemia combined with cerebral hemorrhage related diseases, and belongs to the field of medical technology . Background technique [0002] Stroke is a group of diseases that cause damage to brain tissue due to sudden rupture of blood vessels in the brain or blockage of blood vessels, including ischemic stroke, hemorrhagic stroke and transient ischemic attack. Ischemic stroke is mainly caused by insufficient blood supply to brain tissue due to vascular embolism and / or arteriosclerosis, causing damage to brain tissue, accounting for about 87% of the total, and seriously endangering human health. The prevention of cerebral ischemic diseases is an important direction to reduce the harm of diseases, but the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/216A61P7/02A61P25/00A61P9/10
CPCA61K31/216A61P7/02A61P25/00A61P9/10
Inventor 杜冠华吕扬刘成娣孔令雷张森刘楠楠宋俊科张雯
Owner INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI